|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.2 TWD | -3.10% |
|
-1.97% | -35.18% |
| 03-14 | Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 02-06 | Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer | CI |
Tanvex BioPharma, Inc. announced the resignation of Ken Huang as Accounting officer, effective January 5, 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| -35.18% | 220M | |
| +5.33% | 111B | |
| +12.11% | 105B | |
| -12.56% | 22.34B | |
| -3.70% | 21.93B | |
| -6.03% | 18.59B | |
| -35.21% | 18.12B | |
| -10.86% | 16.96B | |
| +5.10% | 13.7B | |
| +37.57% | 12.45B |
TANVEX BIOPHARMA, INC. 
